1198 related articles for article (PubMed ID: 21996169)
21. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
22. Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.
Wärnberg F; Bergh J; Holmberg L
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):769-74. PubMed ID: 10498395
[TBL] [Abstract][Full Text] [Related]
23. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
[TBL] [Abstract][Full Text] [Related]
24. Positive predictive value of screening mammography by age and family history of breast cancer.
Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
[TBL] [Abstract][Full Text] [Related]
25. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands.
Ripping TM; Verbeek AL; Fracheboud J; de Koning HJ; van Ravesteyn NT; Broeders MJ
Int J Cancer; 2015 Aug; 137(4):921-9. PubMed ID: 25612892
[TBL] [Abstract][Full Text] [Related]
26. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden.
Jonsson H; Johansson R; Lenner P
Int J Cancer; 2005 Dec; 117(5):842-7. PubMed ID: 15957172
[TBL] [Abstract][Full Text] [Related]
27. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
28. Digital Compared with Screen-Film Mammography: Measures of Diagnostic Accuracy among Women Screened in the Ontario Breast Screening Program.
Prummel MV; Muradali D; Shumak R; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ; Chiarelli AM
Radiology; 2016 Feb; 278(2):365-73. PubMed ID: 26334680
[TBL] [Abstract][Full Text] [Related]
29. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
30. Cumulative risk of cancer detection in breast cancer screening by protocol strategy.
Blanch J; Sala M; Román M; Ederra M; Salas D; Zubizarreta R; Sanchez M; Rué M; Castells X;
Breast Cancer Res Treat; 2013 Apr; 138(3):869-77. PubMed ID: 23471648
[TBL] [Abstract][Full Text] [Related]
31. Mammography screening methods and diagnostic results.
Thurfjell E
Acta Radiol Suppl; 1995; 395():1-22. PubMed ID: 7839866
[TBL] [Abstract][Full Text] [Related]
32. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
33. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.
Yen AM; Duffy SW; Chen TH; Chen LS; Chiu SY; Fann JC; Wu WY; Su CW; Smith RA; Tabár L
Cancer; 2012 Dec; 118(23):5728-32. PubMed ID: 22605639
[TBL] [Abstract][Full Text] [Related]
34. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
Bordás P; Jonsson H; Nyström L; Lenner P
J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
[TBL] [Abstract][Full Text] [Related]
35. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
[TBL] [Abstract][Full Text] [Related]
36. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
38. Earlier detection of breast cancer by surveillance of women at familial risk.
Tilanus-Linthorst MM; Bartels CC; Obdeijn AI; Oudkerk M
Eur J Cancer; 2000 Mar; 36(4):514-9. PubMed ID: 10717529
[TBL] [Abstract][Full Text] [Related]
39. Detection of ductal carcinoma in situ in women undergoing screening mammography.
Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
[TBL] [Abstract][Full Text] [Related]
40. Mammography in symptomatic and asymptomatic patients.
Stomper PC; Gelman RS
Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
